NEWS: Dr. Jan Petracek in the Programme Committee at DIA Workshop Benefit/Risk Strategy June 15-16 2017 in Prague
Published 5 May 2017.
Dr. Jan Petracek in the Programme Committee at DIA Workshop Benefit/Risk Strategy June 15-16 2017, Prague
Jan Petracek PrimeVigilance and PharmInvent’s CEO will be sharing his expertise as part of the Programme Committee for DIA’s upcoming Workshop on Benefit/Risk Strategy taking place on June 15th – 16th at the Hotel Grand Majestic Plaza in Prague, Czech Republic.
This workshop is designed to specifically discuss benefit/risk assessment, challenges and solutions related to it within different departments or an organization. Additionally, there will be discussion regarding the impact of the new guidelines and interpretations of them. The workshop brings together regulators and industry from both regulatory and pharmacovigilance departments to discuss the strategic developments within the framework of benefit/risk assessment.